Progression-free survival versus post-progression survival and overall survival in WHO grade 2 gliomas

Autor: Lisa Millgård Sagberg, Øyvind Salvesen, Asgeir Store Jakola, Erik Thurin, Eddie de Dios, Noah L.A. Nawabi, John L. Kilgallon, Joshua D. Bernstock, Vasileios K. Kavouridis, Timothy R. Smith, Ole Solheim

Publikováno v: Acta Oncologica, Vol 63, Iss 1 (2024)

Background and purpose: Progression-free survival (PFS) remains to be validated as an outcome measure for diffuse WHO grade 2 gliomas, and knowledge about the relationships between PFS, post-progression survival (PPS), and overall survival (OS) in th

Externí odkaz: https://doaj.org/article/55c989cdf96f4f42b7ad160fa64d224d

Data from Residual Convolutional Neural Network for the Determination of IDH Status in Low- and High-Grade Gliomas from MR Imaging

Autor: Jayashree Kalpathy-Cramer, Raymond Y. Huang, Li Yang, Bruce R. Rosen, Paul J. Zhang, Elizabeth R. Gerstner, Omar Arnaout, John Woo, Ranjit S. Bindra, Patrick Y. Wen, Keith Ligon, Lori Ramkissoon, Shakti Ramkissoon, Jane Cryan, Bo Xiao, Xuejun Li, Qin Shen, Weihua Liao, Alexandra Capellini, Biqi Zhang, Andrew Beers, Alessandro Boaro, Joeky T. Senders, Vasileios K. Kavouridis, Ena Agbodza, Wenya Linda Bi, Chang Su, Hao Zhou, Harrison X. Bai, Ken Chang

Purpose: Isocitrate dehydrogenase (IDH) mutations in glioma patients confer longer survival and may guide treatment decision making. We aimed to predict the IDH status of gliomas from MR imaging by applying a residual convolutional neural network to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ccdb846235baf170cf7eee8745caaab
https://doi.org/10.1158/1078-0432.c.6525570.v1

Short-term outcomes associated with temozolomide or PCV chemotherapy for 1p/19q-codeleted WHO grade 3 oligodendrogliomas: A national evaluation

Autor: Nayan Lamba, Malia McAvoy, Vasileios K Kavouridis, Timothy R Smith, Mehdi Touat, David A Reardon, J Bryan Iorgulescu

Publikováno v: Neurooncol Pract

Background The optimal chemotherapy regimen between temozolomide and procarbazine, lomustine, and vincristine (PCV) remains uncertain for WHO grade 3 oligodendroglioma (Olig3) patients. We therefore investigated this question using national data. Met

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ee26ad53bd500f99f4651fbece5444b
https://pubmed.ncbi.nlm.nih.gov/35601971

Improved outcomes associated with maximal extent of resection for butterfly glioblastoma: insights from institutional and national data

Autor: Timothy R. Smith, Elisabetta Mezzalira, David A. Reardon, Maya Harary, Vasileios K. Kavouridis, Francesca Siddi, Alessandro Boaro, J. Bryan Iorgulescu

Publikováno v: Acta Neurochirurgica. 163:1883-1894

Butterfly glioblastomas (bGBMs) are grade IV gliomas that infiltrate the corpus callosum and spread to bilateral cerebral hemispheres. Due to the rarity of cases, there is a dearth of information in existing literature. Herein, we evaluate clinical a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bb60d0f8e0baf4774e0ee6cc8762626b
https://doi.org/10.1007/s00701-021-04844-w

Age, pathology and CA-125 are prognostic factors for survival in patients with brain metastases from gynaecological tumours

Autor: S. Nagtegaal, Alexander F. C. Hulsbergen, Marike L. D. Broekman, Charissa Jessurun, Timothy R. Smith, Joost J.C. Verhoeff, E. Van Dorst, Vasileios K. Kavouridis

Publikováno v: Clinical and Translational Radiation Oncology, 24, 11-15. ELSEVIER IRELAND LTD
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology, Vol 24, Iss, Pp 11-15 (2020)

Highlights • The largest cohort of brain metastases patients from gynaecological tumours. • CA-125, age and primary tumour type are prognostic for survival. • This will inform clinical practice and aid the development of new prognostic tools.